India Glycols Limited (INDIAGLYCO) Price & Analysis

Compare

2 Followers

INDIAGLYCO Stock Chart & Stats

₹1007.65

-₹68.05(-5.10%)

At close: Jan 08 4:00 PM EST

₹1007.65

-₹68.05(-5.10%)

Day’s Range― - ―

52-Week Range₹502.50 - ₹1,222.85

Previous CloseN/A

Volume301.52K

Average Volume (3M)19.23K

Market Cap

₹58.50B

Enterprise Value₹78.80B

Total Cash (Recent Filing)₹1.53B

Total Debt (Recent Filing)₹20.55B

Price to Earnings (P/E)23.5

Beta1.67

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.47%

Share Statistics

EPS (TTM)10.05

Shares Outstanding67,026,764

10 Day Avg. Volume24,007

30 Day Avg. Volume19,229

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)0.79

Price to Sales (P/S)0.47

P/FCF Ratio-4.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)50.43

Revenue Forecast (FY)₹43.23B

Bulls Say, Bears Say

Bulls Say

Renewable Feedstock & Sustainability EdgeA feedstock base including renewable, agro-derived inputs gives India Glycols a structural advantage: it reduces exposure to some fossil-fuel feedstock cycles, supports customer demand for sustainable ingredients, and aligns the business with regulatory and consumer trends that persist over years.

Downstream Specialty PortfolioHigher-value downstream and specialty derivatives broaden margin mix and customer stickiness. Serving pharma, personal care and coatings creates diversified demand, reduces reliance on commodity cycles, and supports more durable revenue and margin profiles over the medium term.

Improving ROE And Stable Equity BaseAn improved ROE (10.2%) and a stable equity ratio (~36.5%) indicate better capital efficiency and a reasonable equity buffer. This supports the company’s ability to absorb cyclical shocks and reinvest, provided leverage is managed, and underpins longer-term returns to shareholders.

Bears Say

Negative Free Cash FlowPersistent negative free cash flow (-3.98 billion) driven by high capex weakens internal funding for debt reduction, dividend support or strategic investment. Over a multi-quarter horizon this limits financial flexibility and can force external financing at unfavorable terms.

Rising LeverageAn increased debt-to-equity ratio (~0.84) raises interest and refinancing risk and reduces balance sheet resilience. Higher leverage leaves less room for margin pressure or demand shocks and can constrain investment choices and capital allocation over the medium term.

Margin Pressure And Slowing ProfitabilityThe firm faces margin pressure linked to input cost volatility and product-mix shifts; revenue growth slowed from earlier highs. Combined with higher leverage and negative FCF, sustaining net margins and converting profits into cash is a structural risk for medium-term profitability.

India Glycols Limited News

India Glycols Gets Major Relief as Customs Appeal Cuts Penalties, Plans Second Challenge

India Glycols Limited ( ($IN:INDIAGLYCO) ) has shared an update. India Glycols Limited has disclosed that the Commissioner...

7d ago

India Glycols to Weigh Interim Dividend, Closes Trading Window

India Glycols Limited ( ($IN:INDIAGLYCO) ) just unveiled an announcement. India Glycols Limited has scheduled a board meeting...

10d ago

India Glycols Announces Trading Window Closure Ahead of Financial Results Meeting

India Glycols Limited ( ($IN:INDIAGLYCO) ) has shared an announcement. India Glycols Limited has announced the closure of...

4M ago

India Glycols Announces Dividend Post Share Split

India Glycols Limited ( ($IN:INDIAGLYCO) ) just unveiled an update. India Glycols Limited announced a dividend for the...

6M ago

INDIAGLYCO FAQ

What was India Glycols Limited’s price range in the past 12 months?

India Glycols Limited lowest stock price was ₹502.50 and its highest was ₹1222.85 in the past 12 months.

What is India Glycols Limited’s market cap?

India Glycols Limited’s market cap is ₹58.50B.

When is India Glycols Limited’s upcoming earnings report date?

India Glycols Limited’s upcoming earnings report date is May 21, 2026 which is in 62 days.

How were India Glycols Limited’s earnings last quarter?

India Glycols Limited released its earnings results on Feb 10, 2026. The company reported ₹10.05 earnings per share for the quarter, beating the consensus estimate of N/A by ₹10.05.

Is India Glycols Limited overvalued?

According to Wall Street analysts India Glycols Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does India Glycols Limited pay dividends?

India Glycols Limited pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.47%. See more information on India Glycols Limited dividends here

What is India Glycols Limited’s EPS estimate?

India Glycols Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does India Glycols Limited have?

India Glycols Limited has 67,026,764 shares outstanding.

What happened to India Glycols Limited’s price movement after its last earnings report?

India Glycols Limited reported an EPS of ₹10.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.87%.

Which hedge fund is a major shareholder of India Glycols Limited?

Currently, no hedge funds are holding shares in IN:INDIAGLYCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

India Glycols Limited

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.